BIIB

Biogen
D

BIIB

Arincen57/100B

Biogen balance sheet 1985–2026

Biogen had 1.30B USD in cash and short-term investments on 30 September 2026, against total debt of 7.80B USD: net debt of 6.50B USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q3 FY2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Cash and equivalents
1.30B3.01B2.38B1.05B3.42B2.26B1.33B2.91B1.22B1.57B2.33B
Short-term investments
0.00807.20M0.000.001.47B1.54B1.28B1.56B2.31B2.12B2.57B
1.30B3.82B2.38B1.05B4.89B3.80B2.61B4.48B3.54B3.69B4.90B
Cash growth
-67.08%+60.66%+126.21%-78.54%+28.67%+45.68%-41.69%+26.51%-4.09%-24.64%+42.78%
Receivables
1.88B1.87B1.87B2.10B2.14B1.96B2.33B2.47B2.49B2.32B1.74B
Inventory
2.22B2.17B2.46B2.53B1.34B1.35B1.07B804.20M929.90M902.70M1.00B
Other current assets
2.17B1.12B752.50M1.18B1.42B740.80M881.10M631.00M687.60M304.40M276.30M
Total current assets
7.58B8.97B7.46B6.86B9.79B7.86B6.89B8.38B7.64B7.87B8.73B
Property, plant and equipment
3.14B3.32B3.54B3.73B3.70B3.79B3.84B3.67B3.60B3.18B2.50B
Long-term investments
659.80M750.60M226.70M460.70M705.70M892.00M772.10M1.41B1.38B3.06B2.83B
Goodwill and intangibles
20.37B15.67B16.17B14.58B7.60B7.98B8.85B9.29B8.83B8.51B7.48B
Goodwill
6.99B6.49B6.48B6.22B5.75B5.76B5.76B5.76B5.71B4.63B3.67B
Intangible assets
13.38B9.18B9.69B8.36B1.85B2.22B3.08B3.53B3.12B3.88B3.81B
Other non-current assets
0.00431.90M333.80M284.30M1.53B1.94B2.90B1.25B1.69B431.60M1.34B
Total assets
32.05B29.44B28.05B26.84B24.55B23.88B24.62B27.23B25.29B23.65B22.88B
Accounts payable
430.30M432.00M424.20M403.30M491.50M589.20M454.90M530.80M370.50M395.50M279.80M
Deferred revenue
0.000.000.000.000.000.000.000.000.000.000.00
Short-term debt
400.00M80.40M1.75B150.00M0.00999.10M0.001.50B0.003.20M4.70M
Other current liabilities
1.01B2.72B375.80M335.10M1.14B345.10M515.30M315.80M320.90M297.70M282.90M
Total current liabilities
3.90B3.35B5.53B3.43B3.27B4.30B3.74B4.86B3.30B3.37B3.42B
Long-term debt
7.29B6.58B4.55B6.79B6.28B6.27B7.43B4.46B5.94B5.94B6.51B
Other non-current liabilities
668.40M458.10M732.30M781.10M944.20M1.32B1.33B1.35B1.39B1.63B722.50M
Lease obligations, current
0.000.000.000.000.000.000.000.000.000.000.00
Lease obligations, long-term
109.30M290.40M334.50M400.00M333.00M330.40M402.00M412.70M0.000.000.00
Total liabilities
13.13B11.18B11.33B12.05B11.17B12.92B13.93B13.90B12.26B11.05B10.75B
Common stock and paid-in capital
100.00K100.00K100.00K100.00K100.00K100.00K100.00K100.00K100.00K100.00K100.00K
Retained earnings
20.95B20.55B19.26B17.63B16.47B13.91B13.98B16.46B16.26B15.81B15.07B
Accumulated other comprehensive income
-120.30M-182.00M-136.20M-153.70M-164.90M-106.70M-299.00M-135.20M-240.40M-318.40M-319.90M
Shareholders' equity
18.92B18.26B16.72B14.80B13.40B10.90B10.70B13.34B13.04B12.61B12.14B
Minority interest
0.000.000.000.00-9.50M63.50M-14.20M-4.10M-8.00M-14.70M-11.50M
7.80B6.95B6.63B7.34B6.61B7.60B7.83B6.37B5.94B5.94B6.52B
Net cash
-6.50B-3.13B-4.26B-6.29B-1.72B-3.80B-5.22B-1.89B-2.40B-2.25B-1.62B
Working capital
3.69B5.62B1.93B3.43B6.52B3.56B3.14B3.52B4.35B4.51B5.31B
Book value per share
128.03124.45114.57101.6491.7772.8466.3471.2063.5159.2255.48
Tangible book value
-1.45B2.59B545.90M217.20M5.80B2.91B1.85B4.06B4.21B4.10B4.66B
Tangible book value per share
-9.8117.643.741.4939.7219.4811.4921.6520.5219.2521.31
Current ratio
1.952.681.352.002.991.831.841.722.322.342.55
Debt to equity
0.410.380.400.500.490.700.730.480.460.470.54

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Common questions about Biogen's cash and debt

Source: Financial Modeling Prep